Richard Freed is the CEO and co-founder of RheumaGen and spoke with BioPharmaDispatch during his current trip to Australia.
'We are doing something that most people think is impossible'
November 5, 2024 Latest NewsBioPharmaBioPharmaDispatch ExecutiveLatest Video
New Stories
-
AusBiotech and Life Sciences Western Australia sign first-ever MOU
November 7, 2024 - - Australian Biotech -
The solution simply gives some certainty to submissions that had none
November 7, 2024 - - Latest News -
Rare Cancers Australia set to launch the 2025 Kosi Challenge
November 7, 2024 - - Latest News -
'The fight is not over until this is all resolved, but seeing the system start to move is a great first step'
November 7, 2024 - - Latest News -
PBAC 'directed' to meet for another full meeting in May
November 6, 2024 - - Latest News -
Doctors in Australia lead Phase 3 theranostics study targeting advanced prostate cancer
November 6, 2024 - - Australian Biotech -
Scope of practice final report triggers debate over recommendations for reform
November 6, 2024 - - Latest News